Cargando…
A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
Eosinophilic esophagitis (EoE) is a chronic disease, characterized clinically by esophageal disfunction. Topical corticosteroids (tCS), predominantly fluticasone and budesonide, are considered the effective first line treatment, as well as an option of maintenance therapy in EoE. The way that tCS ar...
Autores principales: | Warzecha, Joanna, Dziekiewicz, Marcin, Bieńkowska-Tokarczyk, Alicja, Małecki, Maciej, Banaszkiewicz, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694526/ https://www.ncbi.nlm.nih.gov/pubmed/36431208 http://dx.doi.org/10.3390/jcm11226730 |
Ejemplares similares
-
Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
por: Casiraghi, Antonella, et al.
Publicado: (2020) -
Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis
por: Ahmet, Alexandra, et al.
Publicado: (2016) -
A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis
por: Oliva, Salvatore, et al.
Publicado: (2019) -
Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis
por: Numan, Laith, et al.
Publicado: (2023) -
Hyperthermia Enhances Adeno-Associated Virus Vector Transduction Efficiency in Melanoma Cells
por: Bieńkowska-Tokarczyk, Alicja, et al.
Publicado: (2023)